Dataset Information


Proteomic analysis upon miR195/497 replacement reveals potential chemo sensitizing candidates for colorectal cancer

ABSTRACT: Patients with advanced colorectal cancer (CRC) are commonly treated with systemic combination therapy but suffer eventually from drug resistance. MicroRNAs (miRNAs) are suggested to play a role in treatment resistance of CRC. We studied whether restoring downregulated miR-195-5p and 497-5p sensitize CRC cells to currently used chemotherapeutics 5-fluorouracil, oxaliplatin and irinotecan. Sensitivity to 5-FU, oxaliplatin and irinotecan before and after transfection with miR-195-5p and miR-497-5p mimics was analyzed in CRC cell lines HCT116, RKO, DLD-1 and SW480. Mass spectrometry based proteomic analysis of transfected and wild-type cells was used to identify targets involved in sensitivity to chemotherapy. Proteomic analysis revealed 181 proteins with significantly altered expression after transfection with miR-195-5p mimic in HCT116 and RKO, including 118 downregulated and 63 upregulated proteins. After transfection with miR-497-5p mimic, 130 proteins were significantly downregulated and 102 were upregulated in HCT116 and RKO (P<0.05 and FC<-3 or FC>3). CHUK and LUZP1 were coinciding downregulated proteins in sensitized CRC cells after transfection with either mimic. Resistance mechanisms of these two proteins may be related to nuclear factor kappa-B signaling and G1 cell cycle arrest, respectively. Restoring miR-195-5p and miR-497-5p expression enhanced sensitivity to chemotherapy, mainly oxaliplatin, in CRC cells and could be a promising treatment strategy for patients with mCRC. Proteomics revealed potential targets of these miRNAs involved in sensitivity to chemotherapy.


ORGANISM(S): Homo sapiens  

TISSUE(S): Tissue Not Applicable To Dataset, Colon

DISEASE(S): Colon Cancer

SUBMITTER: Sander Piersma  

LAB HEAD: Connie Ramona Jimenez

PROVIDER: PXD015369 | Pride | 2019-09-27


altmetric image


Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells.

Poel Dennis D   Boyd Lenka N C LNC   Beekhof Robin R   Schelfhorst Tim T   Pham Thang V TV   Piersma Sander R SR   Knol Jaco C JC   Jimenez Connie R CR   Verheul Henk M W HMW   Buffart Tineke E TE  

Cells 20190919 9

Most patients with advanced colorectal cancer (CRC) eventually develop resistance to systemic combination therapy. miR-195-5p and miR-497-5p are downregulated in CRC tissues and associated with drug resistance. Sensitization to 5-FU, oxaliplatin, and irinotecan by transfection with miR-195-5p and miR-497-5p mimics was studied using cell viability and clonogenic assays in cell lines HCT116, RKO, DLD-1, and SW480. In addition, proteomic analysis of transfected cells was implemented to identify pot  ...[more]

Similar Datasets

2019-01-01 | S-EPMC6770888 | BioStudies
2016-01-01 | S-EPMC4727563 | BioStudies
2019-01-01 | S-EPMC6822233 | BioStudies
2017-01-01 | S-EPMC5351191 | BioStudies
2020-01-01 | S-EPMC7019154 | BioStudies
2020-01-01 | S-EPMC7401935 | BioStudies
2019-01-01 | S-EPMC6827018 | BioStudies
2020-01-01 | S-EPMC7039100 | BioStudies
2018-01-01 | S-EPMC5779689 | BioStudies
2019-01-01 | S-EPMC6423768 | BioStudies